NADclinic and Bontac Bio-Engineering (Shenzhen) Co., Ltd Announce Strategic Partnership to Evolve the Future of Global Wellness Through the Power of NAD+
2024年5月17日 - 6:48PM
ビジネスワイヤ(英語)
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd
have officially entered into a dynamic strategic partnership to
collaboratively focus on the future of global health and wellness.
Synergistically leveraging their collective expertise and
pioneering research in the field of coenzymes and NAD+, both
parties share a common view and philosophy to develop and deliver
the most advanced NAD-based therapeutics and supplement innovation
and products, to those who seek a longer, healthier, and more vital
life.
On 6 May 2024, Bontac Bio-Engineering (Shenzhen) Co., Ltd and
NADclinic Group signed a partnership cooperation agreement,
formalising their ambition to become deep strategic partners.
Nicotinamide Adenine Dinucleotide (NAD+) is a coenzyme central
to metabolism that is found in all living cells. NAD+ is an
essential coenzyme that converts glucose into cellular energy in
the human body, supporting a healthier ageing process, driving
metabolic function, supporting DNA repair, reducing inflammation,
and decreasing our susceptibility to disease and chronic illness.
NAD+ is necessary for over 500 critical enzymatic reactions in the
body.
The partnership between NADclinic and Bontac Bio-Engineering
(Shenzhen) Co., Ltd highlights their joint philosophy for elevating
and emphasising the importance of global NAD+ research, and
collectively developing innovative, science-backed methods to
deliver optimised bioavailability and administration techniques to
support improved patient outcomes. The significant recent growth in
the global NAD+ market is expected to increase exponentially over
the coming years. The partnership between NADclinic Group and
Bontac Bio-Engineering (Shenzhen) Co., Ltd ensures that both
parties are at the forefront of this exciting growth trend in
preventive health innovation, human performance, and longevity.
The collaboration generates excellent synergy by combining
Bontac Bio-Engineering (Shenzhen) Co., Ltd’s coenzyme APIs, NAD+
raw materials, and expertise in NAD-based product development, with
NADclinic’s expansive global footprint and pioneering R&D
within the NAD+ therapy space. NADclinic supports the promotion of
metabolism-boosting NAD+ products vital for human health
optimisation and longevity. The NADclinic brand, known globally for
their innovative, forward-thinking approach and transformative IV
protocols, therapeutics, and supplements, are equally enthusiastic
about the collaboration and the opportunities that working closely
with Bontac Bio-Engineering (Shenzhen) Co., Ltd offers for the
future.
"At NADclinic, we are committed to continuing pioneering
advancements in NAD+ therapeutics and nutraceuticals to empower
individuals to live longer, healthier, more vibrant lives.
NADclinic continues to be the benchmark brand in the NAD+ sector
globally, and working closely with Bontac Bio-Engineering
(Shenzhen) Co., Ltd will only amplify this. Partnering with Bontac
Bio-Engineering (Shenzhen) Co., Ltd aligns perfectly with our own
mission, allowing us to combine and consolidate our expertise and
resources to deliver unparalleled solutions to our clients
worldwide," said Iain De Havilland, the Founder and CEO of
NADclinic.
"We are thrilled to join forces with NADclinic, a company that
shares our commitment to excellence and innovation in the field of
NAD+ therapy. Through this partnership, we aim to leverage our
collective expertise to provide individuals around the world with
access to the highest quality NAD+ products, supporting their
journey towards improved health and vitality," said Professor Zhang
Qi, the Chief Scientist and Founder of Bontac Bio-Engineering
(Shenzhen) Co., Ltd.
About NADclinic Group
NADclinic Group are purveyors of NAD+ therapeutics, NAD+
supplements, and diagnostics. The NADclinic brand is trademarked
internationally, including in the US, and internationally
recognised as a leader in NAD product innovation. Currently,
NADclinic cooperates with 30+ leading clinical brands across the
globe, with their trademark protocol menu being uniformly adopted
by all preferred partners. The NADclinic brand is now active in 40
countries across five continents. NADclinic continues to innovate
and develop the brand internationally, expanding their presence
within the wellness, medical, and top-tier hospitality sectors.
NADclinic Group's ambition to become the dominant specialist NAD
brand internationally, with a particular focus within the B2B and
Corporate Wellness space.
About Bontac Bio-Engineering (Shenzhen) Co., Ltd
Bontac Bio-Engineering (Shenzhen) Co., Ltd is a national
high-tech enterprise specialising in research, development,
production, and sales of biocatalysis and other synthetic biology
technologies. As a pioneer in the NAD+ precursor (NMN) industry, it
holds 173 international research and development patents and has
globally pioneering coenzyme technology. It is the only
provincial-level coenzyme engineering technology research centre in
Guangdong Province, providing a variety of NAD raw materials
products including NAD ER Grade (to remove endotoxins), NAD I Grade
(IVD/dietary supplements/cosmetic raw materials powder), NAD II
Grade (API/intermediates), and NAD IV Grade (if higher solubility
is required). These are widely used in nutritional health,
biomedicine, medical aesthetics, daily chemical products, green
agriculture, and other fields.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240516518164/en/
For more information, please contact: press@nadclinic.com